<DOC>
	<DOC>NCT00644982</DOC>
	<brief_summary>To assess the comparative efficacy of sertraline versus venlafaxine XR on measures of quality of life.</brief_summary>
	<brief_title>A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Primary diagnosis of DSMIV Major Depressive Disorder, single episode or recurrent, without psychotic features. Additional DSMIV Axis I diagnoses will be permitted only if they are identified as secondary diagnoses. HamiltonDepression rating scale (HAMD; 17 item) total score ≥18 and HAMD item 1 (depressed mood) score ≥2. Use of an antidepressant within 2 weeks of baseline (4 weeks for fluoxetine) Current or past diagnosis of bipolar disorder or any psychotic disorder.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>